Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Increases Private Placement by $3M

NEW YORK, April 3 (GenomeWeb News) - Sequenom said today that that its previously announced private stock placement has been increased by $3 million to $33 million.


The company said the increase comes with the addition of Siemens Venture Capital to the list of investors taking part in the placement.


Under the terms of the increased transaction, which remains subject to shareholder approval and other closing conditions, Sequenom will issue 60 million shares of common stock and 36 million warrants exercisable at $.70 per share.


The transaction is expected to close by May 31, the company said. Net proceeds from the transaction will be used for general working capital needs.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.